Trevor Bezdek Biography and Net Worth

Trevor is on a mission to lower the cost of prescriptions in America. Before co-founding GoodRx, Trevor created Tryarc, a technology company delivering strategy and implementation services for healthcare and media organizations. Tryarc became one of the largest private IT services in California, doing business with Anthem/Blue Cross, Toyota and Sony, among others.

In 2007, Trevor sold the company to NTT, where he received the President’s Award for leadership. Previously, Trevor co-founded Biowire, a community for biologists and other scientists to share insights on best practices and resources.

Trevor is an engaged member of his community, serving on the Board of Trustees of Crossroads School for Arts & Sciences and as a member of Young Presidents’ Organization (YPO). Trevor graduated with honors from Stanford University with degrees in biological sciences and computer science.

How old is Trevor Bezdek?: Mr. Bezdek is currently 45 years old. There are 4 older executives and no younger executives at GoodRx. The oldest executive at GoodRx is Mr. Karsten Ian Voermann, CFO & Principal Financial Officer, who is 54 years old. Learn More on Trevor Bezdek's age.
How do I contact Trevor Bezdek?: The corporate mailing address for Mr. Bezdek and other GoodRx executives is 233 WILSHIRE BLVD. SUITE 990, SANTA MONICA CA, 90401. GoodRx can also be reached via phone at 855-268-2822 and via email at [email protected]. Learn More on Trevor Bezdek's contact information.
Has Trevor Bezdek been buying or selling shares of GoodRx?: Trevor Bezdek has not been actively trading shares of GoodRx during the last ninety days. Most recently, Trevor Bezdek sold 64,271 shares of the business's stock in a transaction on Wednesday, December 22nd. The shares were sold at an average price of $35.19, for a transaction totalling $2,261,696.49. Learn More on Trevor Bezdek's trading history.
Who are GoodRx's active insiders?: GoodRx's insider roster includes Babak Azad (Insider), Trevor Bezdek (CEO), Douglas Hirsch (CEO), Bansi Nagji (Insider), Agnes Rey-Giraud (Director), Andrew Slutsky (Insider), Karsten Voermann (CFO), and Scott Wagner (Insider). Learn More on GoodRx's active insiders.
Are insiders buying or selling shares of GoodRx?: During the last twelve months, GoodRx insiders bought shares 3 times. They purchased a total of 129,888 shares worth more than $686,705.16. The most recent insider tranaction occured on November, 30th when insider Scott Wagner bought 21,652 shares worth more than $124,715.52. Insiders at GoodRx own 1.4% of the company. Learn More about insider trades at GoodRx.
Information on this page was last updated on 11/30/2023.

Trevor Bezdek Insider Trading History at GoodRx

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/22/2021	Sell	64,271	$35.19	$2,261,696.49

Trevor Bezdek Buying and Selling Activity at GoodRx

GoodRx Company Overview

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Today's Range

Now: $6.87

$6.52

$6.90

50 Day Range

MA: $6.89

$6.38

$8.35

2 Week Range

Now: $6.87

$4.14

$9.37

Volume

499,975 shs

Average Volume

1,523,162 shs

Market Capitalization

$2.71 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.42

The "Smart Money" Is Ready for May 1st Are You?

From Stansberry Research | Ad

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

One Former Wall St. Trader Explains Why…